Hangzhou, China

Xufeng Cen

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Hangzhou Phecdamed Co., Ltd.. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Xufeng Cen

Xufeng Cen is a notable inventor based in Hangzhou, China. He has made significant strides in the field of small molecule compounds, particularly those with a naphthylamine structure. His work has implications for pharmaceutical applications, showcasing his expertise and innovative spirit.

Latest Patents

Xufeng Cen holds a patent for "Small molecule compounds having naphthylamine structure and application thereof." This patent discloses small molecule compounds that can selectively induce autophagy in damaged mitochondria while minimally affecting normal mitochondria. The compounds provided in this application demonstrate superior metabolic stability, pharmacokinetic properties, lower toxicity, and enhanced druggability. This innovation has the potential to advance therapeutic strategies in medicine.

Career Highlights

Cen is associated with Hangzhou Phecdamed Co., Ltd., where he continues to contribute to the development of innovative pharmaceutical solutions. His work is characterized by a commitment to improving drug efficacy and safety, which is evident in his patented research.

Collaborations

Xufeng Cen collaborates with talented individuals such as Hongguang Xia and Mengyang Fan. These partnerships enhance the research and development efforts at Phecdamed, fostering an environment of innovation and creativity.

Conclusion

Xufeng Cen's contributions to the field of small molecule compounds highlight his role as a leading inventor in the pharmaceutical industry. His innovative work not only advances scientific knowledge but also has the potential to improve patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…